| Year |
Citation |
Score |
| 2021 |
Maksymetz J, Byun NE, Luessen DJ, Li B, Barry RL, Gore JC, Niswender CM, Lindsley CW, Joffe ME, Conn PJ. mGlu potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits. Cell Reports. 37: 109950. PMID 34731619 DOI: 10.1016/j.celrep.2021.109950 |
0.419 |
|
| 2021 |
Wang F, Zu Z, Wu TL, Yan X, Lu M, Yang PF, Byun NE, Reed JL, Gore JC, Chen LM. Sensitivity and specificity of CEST and NOE MRI in injured spinal cord in monkeys. Neuroimage. Clinical. 30: 102633. PMID 33780866 DOI: 10.1016/j.nicl.2021.102633 |
0.357 |
|
| 2021 |
Yang PF, Phipps MA, Jonathan S, Newton AT, Byun N, Gore JC, Grissom WA, Caskey CF, Chen LM. Bidirectional and State-Dependent Modulation of Brain Activity by Transcranial Focused Ultrasound in Non-human Primates. Brain Stimulation. PMID 33460838 DOI: 10.1016/j.brs.2021.01.006 |
0.586 |
|
| 2020 |
Wu TL, Byun NE, Wang F, Mishra A, Janve VA, Chen LM, Gore JC. Longitudinal assessment of recovery after spinal cord injury with behavioral measures and diffusion, quantitative magnetization transfer and functional magnetic resonance imaging. Nmr in Biomedicine. e4216. PMID 31943383 DOI: 10.1002/Nbm.4216 |
0.439 |
|
| 2017 |
Moehle MS, Pancani T, Byun N, Yohn SE, Wilson GH, Dickerson JW, Remke DH, Xiang Z, Niswender CM, Wess J, Jones CK, Lindsley CW, Rook JM, Conn PJ. Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor. Neuron. 96: 1358-1372.e4. PMID 29268098 DOI: 10.1016/J.Neuron.2017.12.008 |
0.343 |
|
| 2017 |
Wu TL, Wang F, Mishra A, Wilson GH, Byun N, Chen LM, Gore JC. Resting-state functional connectivity in the rat cervical spinal cord at 9.4 T. Magnetic Resonance in Medicine. PMID 28905408 DOI: 10.1002/Mrm.26905 |
0.442 |
|
| 2015 |
Rook JM, Xiang Z, Lv X, Ghoshal A, Dickerson JW, Bridges TM, Johnson KA, Foster DJ, Gregory KJ, Vinson PN, Thompson AD, Byun N, Collier RL, Bubser M, Nedelcovych MT, et al. Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents. Neuron. 86: 1029-40. PMID 25937172 DOI: 10.1016/J.Neuron.2015.03.063 |
0.362 |
|
| 2014 |
Byun NE, Grannan M, Bubser M, Barry RL, Thompson A, Rosanelli J, Gowrishankar R, Kelm ND, Damon S, Bridges TM, Melancon BJ, Tarr JC, Brogan JT, Avison MJ, Deutch AY, et al. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1578-93. PMID 24442096 DOI: 10.1038/Npp.2014.2 |
0.509 |
|
| 2013 |
Gregory KJ, Herman EJ, Ramsey AJ, Hammond AS, Byun NE, Stauffer SR, Manka JT, Jadhav S, Bridges TM, Weaver CD, Niswender CM, Steckler T, Drinkenburg WH, Ahnaou A, Lavreysen H, et al. N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement. The Journal of Pharmacology and Experimental Therapeutics. 347: 438-57. PMID 23965381 DOI: 10.1124/Jpet.113.206623 |
0.37 |
|
| 2012 |
Digby GJ, Noetzel MJ, Bubser M, Utley TJ, Walker AG, Byun NE, Lebois EP, Xiang Z, Sheffler DJ, Cho HP, Davis AA, Nemirovsky NE, Mennenga SE, Camp BW, Bimonte-Nelson HA, et al. Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8532-44. PMID 22723693 DOI: 10.1523/Jneurosci.0337-12.2012 |
0.376 |
|
| 2012 |
Bubser M, Byun N, Wood MR, Jones CK. Muscarinic receptor pharmacology and circuitry for the modulation of cognition. Handbook of Experimental Pharmacology. 121-66. PMID 22222698 DOI: 10.1007/978-3-642-23274-9_7 |
0.332 |
|
| 2012 |
Jones CK, Byun N, Bubser M. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 16-42. PMID 21956443 DOI: 10.1038/Npp.2011.199 |
0.33 |
|
| 2010 |
Hackler EA, Byun NE, Jones CK, Williams JM, Baheza R, Sengupta S, Grier MD, Avison M, Conn PJ, Gore JC. Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation. Neuroscience. 168: 209-18. PMID 20350588 DOI: 10.1016/J.Neuroscience.2010.02.057 |
0.512 |
|
| 2010 |
Geng Y, Byun N, Delpire E. Behavioral analysis of Ste20 kinase SPAK knockout mice. Behavioural Brain Research. 208: 377-82. PMID 20006650 DOI: 10.1016/J.Bbr.2009.12.005 |
0.572 |
|
| 2009 |
Sheffler DJ, Williams R, Bridges TM, Xiang Z, Kane AS, Byun NE, Jadhav S, Mock MM, Zheng F, Lewis LM, Jones CK, Niswender CM, Weaver CD, Lindsley CW, Conn PJ. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Molecular Pharmacology. 76: 356-68. PMID 19407080 DOI: 10.1124/Mol.109.056531 |
0.357 |
|
| 2007 |
Byun N, Delpire E. Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice. Neurobiology of Disease. 28: 39-51. PMID 17659877 DOI: 10.1016/J.Nbd.2007.06.014 |
0.497 |
|
| 2004 |
Karadsheh MF, Byun N, Mount DB, Delpire E. Localization of the KCC4 potassium-chloride cotransporter in the nervous system. Neuroscience. 123: 381-91. PMID 14698746 DOI: 10.1016/J.Neuroscience.2003.10.004 |
0.535 |
|
| 2002 |
Howard HC, Mount DB, Rochefort D, Byun N, Dupré N, Lu J, Fan X, Song L, Rivière JB, Prévost C, Horst J, Simonati A, Lemcke B, Welch R, England R, et al. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nature Genetics. 32: 384-92. PMID 12368912 DOI: 10.1038/Ng1002 |
0.499 |
|
| Show low-probability matches. |
